Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753061 | 12675306 | 1 | I | 20160810 | 20160813 | 20160822 | 20160822 | EXP | US-TAKEDA-2016MPI007236 | TAKEDA | 8.00 | YR | M | Y | 28.30000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753061 | 12675306 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 1.3 MG/M2, UNK | 21602 | 1.3 | MG/M**2 | INJECTION | |||||||
| 126753061 | 12675306 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 1 MG, UNK | 21602 | 1 | MG | INJECTION | |||||||
| 126753061 | 12675306 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | UNK | 0 | INJECTION | |||||||||
| 126753061 | 12675306 | 4 | SS | Vincristine | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1.5 MG/M2, UNK | 0 | 1.5 | MG/M**2 | ||||||||
| 126753061 | 12675306 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 3 MG/M2, UNK | 0 | 3 | MG/M**2 | ||||||||
| 126753061 | 12675306 | 6 | SS | Daunorubicin | DAUNORUBICIN | 1 | Intravenous (not otherwise specified) | 25 MG, UNK | 0 | 25 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 126753061 | 12675306 | 7 | SS | Pegaspargase | PEGASPARGASE | 1 | Intravenous (not otherwise specified) | 2500 UNK, UNK | 0 | 2500 | IU | ||||||||
| 126753061 | 12675306 | 8 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intrathecal | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126753061 | 12675306 | 1 | Precursor T-lymphoblastic lymphoma/leukaemia |
| 126753061 | 12675306 | 3 | Precursor T-lymphoblastic lymphoma/leukaemia |
| 126753061 | 12675306 | 4 | Precursor T-lymphoblastic lymphoma/leukaemia |
| 126753061 | 12675306 | 5 | Precursor T-lymphoblastic lymphoma/leukaemia |
| 126753061 | 12675306 | 6 | Precursor T-lymphoblastic lymphoma/leukaemia |
| 126753061 | 12675306 | 7 | Precursor T-lymphoblastic lymphoma/leukaemia |
| 126753061 | 12675306 | 8 | Precursor T-lymphoblastic lymphoma/leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126753061 | 12675306 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126753061 | 12675306 | Abdominal pain | |
| 126753061 | 12675306 | Constipation | |
| 126753061 | 12675306 | Non-cardiac chest pain | |
| 126753061 | 12675306 | Sinus tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126753061 | 12675306 | 1 | 20160718 | 20160730 | 0 | |
| 126753061 | 12675306 | 3 | 20160718 | 20160718 | 0 | |
| 126753061 | 12675306 | 4 | 20160718 | 20160808 | 0 | |
| 126753061 | 12675306 | 5 | 20160718 | 20160809 | 0 | |
| 126753061 | 12675306 | 6 | 20160718 | 20160808 | 0 | |
| 126753061 | 12675306 | 7 | 20160718 | 20160804 | 0 | |
| 126753061 | 12675306 | 8 | 20160718 | 20160725 | 0 |